# CNSP (CNS Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> CNS Pharmaceuticals, Inc. reported $18.06M in total assets and a net loss of $15.98M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CNSP
- Markdown: https://convexityos.com/fundamentals/CNSP.md
- SEC CIK: 0001729427
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001729427&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$16.33M | Operating profit |
| Net Income | FY 2025 | -$15.98M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.51 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$14.04M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $17.21M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $9.77M | $9.29M | $14.10M | $9.30M | $9.81M | $5.06M | $1.85M | $21K |
| Total Operating Expenses | $15.99M | $14.90M | $18.87M | $15.27M | $14.49M | $9.45M | $3.83M | $882K |
| **Operating Income** | -$15.99M | -$14.90M | -$18.87M | -$15.27M | -$14.49M | -$9.45M | -$3.83M | -$882K |
| **EBITDA** | -$15.98M | -$14.90M | -$18.86M | -$15.26M | -$14.47M | -$9.44M | -$3.83M | -$882K |
| Interest Income | -- | -- | $28K | $0 | -- | -- | -- | -- |
| Interest Expense | $15K | $16K | $14K | $7.0K | $9.3K | $3.3K | $26K | $29K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$15.85M | -$14.86M | -$18.85M | -$15.27M | -$14.50M | -$9.46M | -$3.88M | -$7.39M |
| Basic EPS | -$35.75 | -$466.89 | -$55,209,333,733.49 | -$6,189,975,990,396.16 | -$273,360,536,583,472.84 | -$9,443,363,991,065.42 | -$4,638,845,469,295.30 | -$11,597,113,673,238.24 |
| **Diluted EPS** | -$35.75 | -$466.89 | -$55,209,333,733.49 | -$6,189,975,990,396.16 | -$273,360,536,583,472.84 | -$9,443,363,991,065.42 | -$4,638,845,469,295.30 | -$11,597,113,673,238.24 |
| Basic Shares Outstanding | 443.4K | 31.8K | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | 443.4K | 31.8K | 0 | 0 | 0 | 0 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $890K | $1.20M | $3.54M | $3.16M | $2.20M | $1.17M | $3.24M | $1.50M |
| Total Operating Expenses | $2.67M | $2.70M | $4.98M | $5.99M | $3.25M | $2.41M | $4.34M | $3.20M |
| **Operating Income** | -$2.67M | -$2.70M | -$4.98M | -$5.99M | -$3.25M | -$2.41M | -$4.34M | -$3.20M |
| **EBITDA** | -$2.67M | -$2.69M | -$4.97M | -$5.99M | -$3.25M | -$2.41M | -$4.34M | -$3.20M |
| Interest Expense | $3.0K | $4.0K | $6.1K | $2.2K | $2.0K | $4.0K | $6.2K | $2.8K |
| **Net Income** | -$2.50M | -$2.59M | -$4.94M | -$5.96M | -$3.22M | -$2.38M | -$4.30M | -$3.18M |
| Basic EPS | -$0.24 | -$0.38 | -$7.30 | -- | -$5.76 | -$6.42 | -$18.93 | -- |
| **Diluted EPS** | -$0.24 | -$0.38 | -$7.30 | -- | -$5.76 | -$6.42 | -$18.93 | -- |
| Basic Shares Outstanding | 10.6M | 6.8M | 676.2K | -- | 558.9K | 370.1K | 227.2K | -- |
| Diluted Shares Outstanding | 10.6M | 6.8M | 676.2K | -- | 558.9K | 370.1K | 227.2K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.20M | $6.46M | $549K | $10.06M | $5.00M | $14.04M | $7.24M | $283K |
| **Cash & Short-Term Investments** | $7.20M | $6.46M | $549K | $10.06M | $5.00M | $14.04M | $7.24M | $283K |
| **Total Current Assets** | $8.10M | $8.66M | $1.59M | $12.56M | $7.48M | $15.50M | $7.89M | $588K |
| Property, Plant & Equipment, Net | $18K | $6.0K | $4.9K | $5.7K | $16K | $23K | $18K | $0 |
| **Total Non-Current Assets** | $521K | $42K | $110K | $488K | $1.28M | $358K | $18K | $95K |
| **Total Assets** | $8.62M | $8.70M | $1.70M | $13.05M | $8.76M | $15.85M | $7.91M | $683K |
| Accounts Payable | -- | -- | -- | $3.68M | $1.98M | $946K | $244K | $128K |
| Short-Term Debt | -- | -- | -- | -- | -- | $482K | -- | -- |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | $0 | $763K |
| **Total Current Liabilities** | $4.10M | $2.52M | $6.13M | $4.92M | $2.59M | $1.91M | $311K | $1.23M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $4.10M | $2.52M | $6.13M | $4.92M | $2.59M | $1.91M | $311K | $1.23M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $482K | -- | -- |
| Common Stock | $1.0K | $118 | $2 | $1.6K | $949 | $24K | $16K | $13K |
| Retained Earnings | -$100.3M | -$84.42M | -$69.57M | -$50.72M | -$35.44M | -$20.95M | -$11.49M | -$7.61M |
| **Total Stockholders' Equity** | $4.52M | $6.18M | -$4.43M | $8.13M | $6.16M | $13.95M | $7.60M | -$549K |
| Total Equity | $4.52M | $6.18M | -$4.43M | $8.13M | $6.16M | $13.95M | $7.60M | -$549K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.21M | $19.98M | $2.95M | $7.20M | $9.86M | $12.13M | $13.05M | $6.46M |
| **Cash & Short-Term Investments** | $17.21M | $19.98M | $2.95M | $7.20M | $9.86M | $12.13M | $13.05M | $6.46M |
| **Total Current Assets** | $18.05M | $21.92M | $4.08M | $8.10M | $11.39M | $14.14M | $13.72M | $8.66M |
| Property, Plant & Equipment, Net | $14K | $15K | $22K | $18K | $3.1K | $3.8K | $4.9K | $6.0K |
| **Total Non-Current Assets** | $14K | $15K | $575K | $521K | $478K | $370K | $27K | $42K |
| **Total Assets** | $18.06M | $21.94M | $4.65M | $8.62M | $11.87M | $14.51M | $13.75M | $8.70M |
| **Total Current Liabilities** | $2.36M | $3.74M | $4.58M | $4.10M | $1.96M | $1.38M | $2.78M | $2.52M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.36M | $3.74M | $4.58M | $4.10M | $1.96M | $1.38M | $2.78M | $2.52M |
| Common Stock | $2.0K | $2.0K | $811 | $1.0K | $574 | $504 | $2.9K | $118 |
| Retained Earnings | -$110.3M | -$107.8M | -$105.2M | -$100.3M | -$94.32M | -$91.10M | -$88.73M | -$84.42M |
| **Total Stockholders' Equity** | $15.71M | $18.20M | $71K | $4.52M | $9.91M | $13.12M | $10.97M | $6.18M |
| Total Equity | $15.71M | $18.20M | $71K | $4.52M | $9.91M | $13.12M | $10.97M | $6.18M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$15.85M | -$14.86M | -$18.85M | -$15.27M | -$14.50M | -$9.46M | -$3.88M | -$7.39M |
| Depreciation & Amortization | $3.9K | $3.3K | $4.1K | $12K | $13K | $11K | $2.0K | $0 |
| Stock-Based Compensation | $188K | $839K | $1.01M | $1.20M | $1.72M | $1.29M | $477K | $110K |
| Change in Payables | -- | -- | -- | $1.70M | $1.04M | $703K | $109K | $86K |
| **Operating Cash Flow** | -$13.81M | -$17.11M | -$14.14M | -$10.56M | -$13.54M | -$7.32M | -$3.55M | -$716K |
| Capital Expenditure | -$18K | -$4.2K | -$3.9K | -$4.4K | -$5.7K | -$18K | -$20K | $0 |
| **Free Cash Flow** | -$13.83M | -$17.12M | -$14.14M | -$10.56M | -$13.54M | -$7.34M | -$3.57M | -$716K |
| **Investing Cash Flow** | -$18K | -$4.2K | -$3.9K | -$4.4K | -$5.7K | -$18K | -$20K | $0 |
| Common Stock Issued | $14.05M | $23.38M | $2.32M | $16.04M | $4.65M | -- | $10.29M | $390K |
| **Financing Cash Flow** | $14.57M | $23.03M | $4.64M | $15.61M | $4.51M | $14.13M | $10.26M | $1.16M |
| **Net Change in Cash** | $740K | $5.91M | -$9.51M | $5.05M | -$9.03M | $6.80M | $6.69M | $445K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.50M | -$2.59M | -$4.94M | -$5.96M | -$3.22M | -$2.38M | -$4.30M | -$3.18M |
| Depreciation & Amortization | $0 | $11K | $1.9K | $918 | $1.0K | $900 | $1.1K | $985 |
| Stock-Based Compensation | $25K | $2.0K | $2.6K | $85K | $19K | $22K | $62K | $130K |
| **Operating Cash Flow** | -$2.77M | -$3.54M | -$4.65M | -$3.05M | -$2.17M | -$5.34M | -$3.24M | -$5.47M |
| Capital Expenditure | $0 | -$3.8K | -$6.2K | -$18K | $0 | $0 | $0 | -- |
| **Free Cash Flow** | -$2.77M | -$3.54M | -$4.65M | -$3.07M | -$2.17M | -$5.34M | -$3.24M | -- |
| **Investing Cash Flow** | $0 | -$3.8K | -$6.2K | -$18K | $0 | $0 | $0 | -- |
| Common Stock Issued | -- | -- | $501K | -- | -- | -- | $9.03M | $5.00M |
| **Financing Cash Flow** | $0 | $20.58M | $405K | $407K | -$92K | $4.43M | $9.83M | $4.96M |
| **Net Change in Cash** | -$2.77M | $17.03M | -$4.25M | -$2.66M | -$2.27M | -$918K | $6.59M | -$512K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -350.4% | -240.5% | -- | -187.8% | -235.2% | -67.8% | -51.0% | -- |
| Return on Assets (ROA) | -183.8% | -170.8% | -1108.3% | -117.0% | -165.5% | -59.7% | -49.0% | -1081.7% |
| Current Ratio | 1.98x | 3.43x | 0.26x | 2.55x | 2.88x | 8.13x | 25.38x | 0.48x |
| Quick Ratio | 1.76x | 2.56x | 0.09x | 2.04x | 1.93x | 7.37x | 23.28x | 0.23x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.03x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -101.7% | -91.8% | -23219.1% | -350.4% | -131.9% | -117.8% | -142.3% | -240.5% |
| Return on Assets (ROA) | -88.5% | -76.1% | -354.3% | -183.8% | -110.1% | -106.6% | -113.6% | -170.8% |
| Current Ratio | 7.65x | 5.86x | 0.89x | 1.98x | 5.81x | 10.22x | 4.94x | 3.43x |
| Quick Ratio | 7.30x | 5.35x | 0.64x | 1.76x | 5.03x | 8.77x | 4.69x | 2.56x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
